COVID survivors lose vision to Black fungus Mucormycosis in Gujarat

"As of now, 50 mucormycosis patients are getting treated at Kiran Hospital and 60 others are awaiting (treatment). They all came to our hospital in the last three weeks. All the patients who are suffering from mucormycosis had recovered from COVID recently," said Savani.

Published On 2021-05-10 04:30 GMT   |   Update On 2021-05-10 04:30 GMT
Advertisement

New Delhi: Cases of Mucormycosis, a fungal infection, affecting some COVID-19 survivors are on the rise in Gujarat which has left many patients blind, doctors and officials claimed on Saturday.

Mathur Savani, chairman of Surat-based Kiran Super multi-speciality hospital, said mucormycosis was detected in a patient who had recovered from COVID-19 disease around three weeks back.

Also Read: Bharat Serums gets DCGI nod to covid linked black fungus drug

Advertisement

"This number has gone up to around 50 now while 60 more such patients are awaiting treatment," Savani told PTI.

The hospital, which is managed by a trust, has been receiving several patients diagnosed with Mucormycosis who are being referred from various areas in Surat and other parts of Gujarat, he said.

"As of now, 50 mucormycosis patients are getting treated at Kiran Hospital and 60 others are awaiting (treatment). They all came to our hospital in the last three weeks. All the patients who are suffering from mucormycosis had recovered from COVID-19 recently," said Savani.

According to Savani, seven such patients have lost their eyesight so far.

Meanwhile, considering the growing number of patients with mucormycosis, Surat's civil hospital has set up a separate facility for their treatment, said in-charge Resident Medical Officer (RMO) Dr Ketan Naik.

He said a separate facility with the dedicated medical staff has been created which will soon start treating patients with mucormycosis.

In Ahmedabad, at least five patients with mucormycosis are being operated upon every day at the civil hospital at Asarva, a senior doctor said.

"In Ahmedabad, we are receiving 5 to 10 such cases at the civil hospital, especially since the second wave of COVID-19 started. These patients are being examined on priority and operated on as early as possible," said Dr Devang Gupta, ENT doctor at the city civil hospital.

He said various resources, including manpower, equipment and injection required for the treatment of mucormycosis patients, have been provided by the government.

"At least one out of the five such cases is related to eyes. Several of them (patients) are suffering from blindness," he said.

Niti Aayog Member (Health) V K Paul on Friday said mucormycosis is being found in patients with COVID-19 disease.

"It is caused by a fungus named mucor, which is found on wet surfaces. It, to a large extent, is happening to people who have diabetes. It is very uncommon in those who are not diabetic. There is no big outbreak and we are monitoring it," he had said.

According to Dr Paul, mucor attacks people with uncontrolled sugar.

He had also said when the same COVID-19 patient is put on oxygen support, which has a humidifier containing water, the chances of him or her getting the fungal infection increase.

As of May 7, Gujarat's COVID-19 tally stood at 6,58,036 while the overall toll is 8,154. The total count of recoveries stood at 5,03,497.

Also Read:IT norms eased: Govt permits cash payment of over Rs 2 lakh for COVID-19 Treatment at hospitals

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News